SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001720725-21-000095
Filing Date
2021-11-04
Accepted
2021-11-04 16:53:06
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q oyst-20210930.htm   iXBRL 10-Q 1290870
2 EX-10.1 exhibit101-creditagreement.htm EX-10.1 1262462
3 EX-10.2 exhibit102-jixinglicensing.htm EX-10.2 616460
4 EX-31.1 oyst-q3x21ex311.htm EX-31.1 12617
5 EX-31.2 oyst-q3x21ex312.htm EX-31.2 12630
6 EX-32.1 oyst-q3x21ex321.htm EX-32.1 7326
7 EX-32.2 oyst-q3x21ex322.htm EX-32.2 7879
  Complete submission text file 0001720725-21-000095.txt   8733211

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oyst-20210930.xsd EX-101.SCH 54426
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oyst-20210930_cal.xml EX-101.CAL 98701
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oyst-20210930_def.xml EX-101.DEF 234758
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oyst-20210930_lab.xml EX-101.LAB 623432
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oyst-20210930_pre.xml EX-101.PRE 425487
13 EXTRACTED XBRL INSTANCE DOCUMENT oyst-20210930_htm.xml XML 1016661
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39112 | Film No.: 211380819
SIC: 2836 Biological Products, (No Diagnostic Substances)